TARGETED LIPID THERAPEUTICS

DELIVERING BETTER OUTCOMES THROUGHOUT LIFE

WHAT WE DO

Actively Transported Lysophospholipids (ATLs) are a promising new class of lipid-based therapeutics that are actively transported by the major facilitator superfamily domain–containing 2a (MFSD2a) protein in a tissue specific manner. Vanteres focuses on using its knowledge of MFSD2a biology to develop ATLs for a wide range of disease states.

Learn More

 


Deprecated: wp_make_content_images_responsive is deprecated since version 5.5.0! Use wp_filter_content_tags() instead. in /home/vanteres/vanteres.com/public_html/wp-includes/functions.php on line 4773

PARTNERS